Posts Tagged ‘Canada’

Jury recommends major reforms in drug prescribing after investigation of 18-year-old’s suicide under the influence of Paxil

Wednesday, June 30th, 2010

Pharmalot
By Ed Silverman
June 30, 2010

There have been numerous claims that a medication caused a suicide, but few lead to sweeping changes. In Canada, however, the suicide of 18-year-old Sarah Carlin, who had taken the Paxil antidepressant, is a clear exception. Following a coroner’s inquest, Canada’s provincial and federal governments were told to ensure patients are better informed about drug risks, tighten regulations on drugmakers and establish an independent agency to regulate medications.

“If these things had been in place at the time Sara was prescribed Paxil, she would be alive today,” her father, Neil Carlin, said outside court. “We consider this a great victory…We are truly confident that if these are acted upon there will be young lives saved down the road.”

For more than a year before her death, Sara had been taking Paxil, an anti-depressant, which Health Canada warns can increase the risk of suicidal events in children and adolescents under 18. The teenager hanged herself in her parents’ basement in May 2007. The inquest made numerous recommendations, which you can see if you keep reading…

Of the various recommendations, the one that is garnering the most discussion appears to be the creation of a Drug Safety Board to investigate the side effects and issue warnings to the public, doctors and hospitals. The inquest specifically recommended the new board not receive any funding from drugmakers. Drugmakers must also report all adverse events to Health Canada within 30 days.

A Glaxo spokeswoman writes to says the drugmaker “is supportive of appropriate recommendations designed to prevent similar tragedies from occurring in the future, and will give the recommendations addressed to the broader pharmaceutical industry our full attention and consideration. Sara Carlin’s death was a tragedy and we continue to express our deepest sympathies to her family.”

1. The Ministry of Health and Long-Term Care (MOHLTC) should develop a Drug Information System. This system would promote:
• Patient safety in the prescribing and dispensing of drugs.
• Collection and compilation of data in a single repository for all drugs dispensed for all Ontarians.
• Research into drug and patient safety.

2. The Drug Information System should track and monitor all drugs dispensed in Ontario regardless of who is paying for the prescription.

3. The Drug Information System should collect, compile and release data upon request to scientists such as those studying population-based health outcomes at the Institute for Clinical Evaluative Sciences.

4. The Ministry of Health and Long-Term Care should commit to developing a province-wide suicide prevention strategy as has occurred in other provinces such as Alberta.

5. The objectives of the province-wide suicide prevention strategy should include:
• Enhanced mental health and well being for Ontarians.
• The education of the public to de-stigmatize mental health disorders, including depression and substance abuse disorders.
• Improving intervention and support for Ontarians affected by depression and substance abuse.
• Improving intervention and treatment for those at risk of suicide.
• Increased efforts to reduce access to lethal means of suicide.
• Increased research activities in Ontario on suicide, suicidal behaviour and suicide prevention.
• Improved suicide and suicidal behaviour-related surveillance systems.
• Inform and educate the media into strategies when reporting deaths due to suicide to prevent ‘copy cat’ suicides from occurring.

6. Strategies in the province-wide suicide prevention strategy should be humane, effective and evidence based, respectful of community and culture-based knowledge, inclusive of research, surveillance, evaluation and reporting and reflective of evolving knowledge and practices.

7. The ministry of Health and Long-Term Care of Ontario and Government of Ontario should commit to supporting the development of a national suicide prevention strategy for all Canadians.

Read entire article:  http://www.pharmalot.com/2010/06/sara-carlin-paxil-and-drug-safety-in-canada/

« Return to news items


  • Share/Bookmark

IMS Health Canada: New study shows psychiatric drug side effects putting people at risk of an early death

Monday, June 14th, 2010

The Vancouver Sun
By Sharon Kirkey
June 14, 2010

The risk of coronary heart disease and a cluster of conditions known as metabolic syndrome increases soon after otherwise healthy, but depressed people are started on psychiatric drugs, putting them at risk for an early death, Canadian researchers are reporting.

Antidepressants, antipsychotics and other psychoactive drugs are the second most-prescribed drug class in the country, second only to cardiovasculars, according to prescription drug-tracking firm IMS Health Canada.

Across Canada, retail pharmacies last year dispensed 61.2 million prescriptions for psychotherapeutics, worth nearly $2.4 billion.

“Usually five of the top 10 prescribed medications worldwide are psychiatric drugs. We need to start looking at the impact of these medications on other systems,” says Dr. Valerie Taylor, an assistant professor in psychiatry and behavioral neurosciences at St. Joseph’s health care and McMaster University in Hamilton.

In a study published this week in the Canadian Journal of Psychiatry, Taylor and her colleagues followed 52 patients, age 16 to 40, newly diagnosed with bipolar disorder or major depressive disorder.

Many were university students who had become ill for the first time. All were “treatment naive” — they had never before been treated for a psychiatric illness.

At the start of the study, researchers measured waist circumference, blood pressure, blood fats and other markers of metabolic syndrome — the name for a grab-bag of health problems that increase the risk of diabetes and cardiovascular disease.

People with metabolic syndrome are twice as likely to die from, and three times as likely to have a heart attack or stroke compared to people without the disorder. They also have up to a nine-fold greater risk of developing type 2 diabetes.

Read entire article:  http://www.vancouversun.com/health/Psychiatric+drugs+carry+serious+physical+health+risks/3153278/story.html

« Return to news items


  • Share/Bookmark

Electroshock Survivor & Human Rights Activist Calls on Amnesty International to Deem Electroshock (ECT) as Torture

Monday, June 14th, 2010

Baby Care
June 14, 2010

Sue Clark-Wittenberg, director of the Wittenberg Center to End Electroshock in Ottawa, Canada is an electroshock survivor who is appealing to Amnesty International to deem electroshock (ECT) as torture. Sue is a torture victim of electroshock.

Dr. Peter R. Breggin, a psychiatrist from NY State wrote an article recently re ECT called “Disturbing News for Patients and Shock Doctors Alike” which proves ECT always causes brain damage 100% of the time. See the article in full at this URL: www.huffingtonpost.com/dr-peter-breggin/

In America, electroshock is not deemed as torture by Amnesty International. ECT is being given more and more especially to women with post partum depression and to women over 60 years of age. Many people all over the world are working to ban electroshock universally. Yearly stats for ECT given:

Ontario, Canada – 14000 ECTs given
USA – 100000 Americans get ECT
UK – 50000 ECT given
Worldwide – 1 to 2 million people get ECT

Read entire article:  http://babies.secretbest.com/19814/electroshock-is-torture/

« Return to news items


  • Share/Bookmark

Psychiatric Industry claims 30 million kids in China have mental disorders—that’s nearly the entire population of Canada

Friday, June 11th, 2010

AllVoices.com
By BMcPherson
June 11, 2010

Information coming out of China has the number of young people with mental disorders pegged at 30 million. That’s nearly the whole population of Canada. This is compared to a Chinese population of over 300 million under the age of 17.

To think that nearly one in 10 young people in China have some sort of mental derangement is very disturbing, considering that they have the world’s largest standing army, are nuclear weaponized and are becoming the world’s big boy with regard to global trade.

“The number 30 million is based on regional researches in recent years. Since the mental health of children must have worsened over time, the real number could be even higher,” said Cui Yonghua, a child psychiatrist with the Beijing Anding Hospital.”China Daily

Further reading brings about a big sigh of relief, however. Most behaviors described by the experts in China are what we in the decadent West consider normal behaviors…

Read entire article:  http://www.allvoices.com/contributed-news/6040479-30-million-youngsters-in-china-have-mental-disorders

« Return to news items


  • Share/Bookmark

Children on antipsychotics 3 times more likely to develop diabetes (a known side effect of antipsychotics)

Thursday, November 12th, 2009

Kelly Sinoski
Vancouver Sun
November 11, 2009

Children and youth on certain antipsychotic medications are more prone to getting diabetes and becoming fat, according to a new study published in the Canadian Journal of Psychiatry.

But the British Columbia doctors involved in the two-year study say parents shouldn’t rush to take their children off the drugs and instead should consult their physicians on ways to monitor and beat the metabolic side-effects.

“On the one hand, the medication has significant and worrying side-effects,” said study co-author Dr. Jana Davidson, medical director of child and adolescent mental health and addiction programs at BC Children’s Hospital.

“On the other hand, in some of these cases the kids being on medication is what allows them to function in their lives and allows them to stay in their families.”

About 6,000 youth in B.C. are on antipsychotic medications and prescription rates have been soaring in the past five years, according to the study.

Between 2002 and 2006, prescriptions of atypical or second-generation antipsychotics for B.C. youth rose by about 22 per cent, from one in 200 youth to one in 154.

Read entire article: http://www.vancouversun.com/health/Children+antipsychotic+drugs+more+prone+diabetes+Canadian+study/2212393/story.html

« Return to news items


  • Share/Bookmark